Citation

Visentin P, Ciravegna R, Corcelli F, Fabris F. Epidemiol. Prev. 1998; 22(1): 44-48.

Vernacular Title

Costo-efficacia della prevenzione delle fratture di femore.

Affiliation

U.O.A.D.U. Geriatria Azienda Ospedaliera San Giovanni Battista, Torino.

Copyright

(Copyright © 1998, Cooperativa Epidemiologia E Prevenzione)

DOI

unavailable

PMID

9621504

Abstract

We estimated the Cost Per Avoided Hip Fracture (CPAHF, millions Lira) by osteoporosis treatment, on the basis of a review on randomized controlled trials. Prevention with vitamin D3 in institutionalized elderly women is cost-neutral (CPAHF = -4; 95% CI = -9, +5). Prevention with alendronate in non-institutionalized women screened on bone mineral density generates doubts (CPAHF = 275; 95% CI = 146, 19.426). The cost-effectiveness analyses can strengthen or weaken conclusions of the clinical trials and discourage the use of economically unsustainable preventive treatments whose efficacy is unproven.

Language: it